The Journal of Clinical Oncology podcast, hosted by Dr. Shannon Westin and Dr. Davide Soldato, presents analyses and discussions centered on the latest findings published in ASCO’s esteemed Journal of Clinical Oncology. Through scholarly discourse and examination, this podcast is your resource for navigating oncological advancements and how they impact clinical practice. The JCO Podcast also features in depth summaries and interviews hosted by the year’s fellows in the series, JCO Article In ...
…
continue reading
The coolest club you never want to be a part of… The team on the You, Me & the Big C podcast are your BFF’s, your sisters, brothers, fathers and mothers. A candid look at cancer, with Steve Bland, Deborah James and Lauren Mahon. Founded by Rachael Bland.
…
continue reading
Featuring one-on-one interviews conducted by Dr Neil Love, this series provides medical oncologists with access to an array of important perspectives and information on relevant advances in the treatment of hematologic cancer to facilitate optimal patient care.
…
continue reading
Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology-oncology fellows ongoing access to the perspectives and opinions of national and international breast cancer clinical investigators.
…
continue reading

1
PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast
PVI, PeerView Institute for Medical Education
PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support ...
…
continue reading

1
Plenary Session - inactive due to federal service
Plenary Session - inactive due to federal service
Dr Prasad currently serves as the Director of the Center for Biologics Evaluation and Resesarch (CBER) at the US FDA. The audio on this platform were posted before my FDA employment and do not necessarily represent the views of the FDA or the United States. This site will be inactive during my federal service. A podcast on medicine, oncology, & health policy. Host: Vinay Prasad, MD MPH from University of California San Francisco. Tweet your feedback to @Plenary_Session or e-mail plenarysessi ...
…
continue reading
Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology/oncology fellows ongoing access to the perspectives and opinions of national and international research leaders with an expertise in thoracic oncology.
…
continue reading
JCO OP: Put Into Practice highlights new research published in JCO OP related to cancer care delivery, quality, disparities, access. Host Dr. Fumiko Chino, MD FASCO interviews thought leaders in oncology to give listeners practical knowledge that can be used in day-to-day practice along with solution-oriented discussions and care innovations.
…
continue reading
The Lancet Oncology is a monthly journal, renowned for the publication of high-quality peer reviewed research, reviews and analysis in cancer from around the world. In the monthly podcasts, editors of the journal discuss highlights of the current issue.
…
continue reading
This series bridges the gap between research and patient care by providing medical oncologists and hematologists with ongoing access to the perspectives and opinions of national and international clinical investigators with expertise in gastrointestinal cancers.
…
continue reading
This series bridges the gap between research and patient care by providing medical and gynecologic oncologists with access to the latest research developments and expert perspectives on up-to-date clinical management strategies for gynecologic cancers.
…
continue reading
Interviews with authors of articles from JAMA Oncology. JAMA Oncology is the definitive journal for scientists, clinicians, and trainees in the field of oncology worldwide. Our original, innovative, and timely scientific and educational content provides a deeper understanding of cancer pathogenesis and recent treatment advances for our readers. JAMA Oncology aims to effectively convey the findings of important clinical research, major scientific breakthroughs, actionable discoveries, and sta ...
…
continue reading
Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.
…
continue reading
From chemotherapy appointments to artificial intelligence, we explore the stories from the people affected by cancer and find out about the cutting-edge research unravelling its mysteries. Hosted on Acast. See acast.com/privacy for more information.
…
continue reading
Featuring one-on-one discussions with leading oncology investigators, this series assists clinicians with the formulation of up-to-date clinical management strategies so that they can provide optimal care for patients with melanoma and nonmelanoma skin cancer.
…
continue reading
ASCO Education: By the Book features engaging discussions between editors and authors from the ASCO Educational Book. Hear nuanced views on topics featured in Education Sessions at ASCO meetings and deep dives on the approaches shaping modern oncology that have care teams talking.
…
continue reading
The ASCO Daily News Podcast features oncologists discussing the latest research and therapies in their areas of expertise.
…
continue reading
Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing urologists and radiation oncologists ongoing access to the perspectives and opinions of national and international prostate cancer research leaders.
…
continue reading
OncoPharm is a podcast dedicated to all things oncology pharmacy. Most episodes cover updates and recent publications concerning the use of medications in caring for patients with cancer. Periodically, episodes drop devoted to Landmark Clinical Trials in oncology and Fundamentals of Oncology Pharmacy.
…
continue reading
Experts from Johns Hopkins Kimmel Cancer Center discuss the latest innovations in research and cancer care.
…
continue reading
CancerCare's free Connect Education Workshops are a way for people to learn about cancer-related issues from the convenience of their home or office. Leading experts in oncology provide the most up-to-date information in these workshops to help you and your loved ones better understand and cope with your cancer diagnosis, treatment options, quality-of-life concerns, treatment side effects, pain management, doctor-patient communication and other important topics.
…
continue reading
This program opens up the sometimes mysterious world of healthcare and how doctors think in an effort to empower the listener to gain better access to effective health care. Discussions are topical and aim to give the listener deeper understanding. The overall goals are knowledge and empowerment around healthcare for you and your loved one Dr. Anderson is a recognized educator and clinician in integrative and naturopathic medicine with a focus on complex infectious, chronic and oncologic ill ...
…
continue reading
MediCom Oncology Clinical Pearl Podcasts provide practical, evidence-based recommendations on real-world issues in the clinical setting, in under three minutes. Leading experts and academic faculty from top research and practice institutions provide guidance to community-based healthcare providers, including oncologists, pharmacists and nurses. Podcasts are brought to you by MediCom Worldwide, Inc., an accredited, independent medical education company. Podcasts are intended for licensed adul ...
…
continue reading
CancerCare's free Connect Education Workshops are a way for people to learn about cancer-related issues from the convenience of their home or office. Leading experts in oncology provide the most up-to-date information in these workshops to help you and your loved ones better understand and cope with your cancer diagnosis, treatment options, quality-of-life concerns, treatment side effects, pain management, doctor-patient communication and other important topics.
…
continue reading
CancerCare's free Connect Education Workshops are a way for people to learn about cancer-related issues from the convenience of their home or office. Leading experts in oncology provide the most up-to-date information in these workshops to help you and your loved ones better understand and cope with your cancer diagnosis, treatment options, quality-of-life concerns, treatment side effects, pain management, doctor-patient communication and other important topics.
…
continue reading
Official podcast of the Breast Cancer Research Foundation
…
continue reading
In OncLive® On Air, you can expect to hear interviews with academic oncologists on the thought-provoking oncology presentations they give at the OncLive® State of the Science Summits. The topics in oncology vary, from systemic therapies, surgery, radiation therapy, to emerging therapeutic approaches in a particular type of cancer. This includes lung cancer, breast cancer, gastrointestinal cancers, hematologic malignancies, gynecologic cancers, genitourinary cancers, and more.
…
continue reading
CancerCare's free Connect Education Workshops are a way for people to learn about cancer-related issues from the convenience of their home or office. Leading experts in oncology provide the most up-to-date information in these workshops to help you and your loved ones better understand and cope with your cancer diagnosis, treatment options, quality-of-life concerns, treatment side effects, pain management, doctor-patient communication and other important topics.
…
continue reading
CancerCare's free Connect Education Workshops are a way for people to learn about cancer-related issues from the convenience of their home or office. Leading experts in oncology provide the most up-to-date information in these workshops to help you and your loved ones better understand and cope with your cancer diagnosis, treatment options, quality-of-life concerns, treatment side effects, pain management, doctor-patient communication and other important topics.
…
continue reading
In the American Association for Cancer Research (AACR) scientific podcasts, we provide interviews with cancer researchers about their latest work as well as recordings of AACR teleconferences.
…
continue reading
Welcome to The Cancer Dietitian Podcast! Join Julie Lanford, MPH, RD, CSO, LDN, a bonafide expert in oncology nutrition, as she guides you through the forest of nutrition and cancer information. Are you a cancer patient wondering what to eat to keep your body as healthy as possible during treatment? Are you a cancer survivor wanting to eat as healthy as possible to reduce the risk of recurrence? Are you sick of all the crazy info around nutrition and just want an evidence-based resource for ...
…
continue reading
Dr. Jack West reviews emerging new information and controversial topics in health care in general, cancer treatment in particular.
…
continue reading
In this series from Cancer Council NSW, Julie McCrossin chats to cancer experts and people affected by a cancer diagnosis. Get information and insights as we explore all things cancer.
…
continue reading

1
Multiple Myeloma — Fourth Annual National General Medical Oncology Summit
50:41
50:41
Play later
Play later
Lists
Like
Liked
50:41Clinical investigators discuss available data guiding the management of multiple myeloma. CME information and select publications here.By Dr. Neil Love
…
continue reading

1
JCO at ASCO Annual Meeting: Avelumab Plus Cetuximab vs. Avelumab in Advanced cSCC
8:42
8:42
Play later
Play later
Lists
Like
Liked
8:42JCO Editorial Fellow Dr. Ece Cali Daylan and JCO Associate Editor Dr. Grant McArthur discuss the ASCO 2025 Simultaneous Publication paper "A Phase II (Alliance A091802) Randomized Trial of Avelumab Plus Cetuximab vs. Avelumab Alone in Advanced Cutaneous Squamous Cell Carcinoma (cSCC)." Transcript The guest on this podcast episode has no disclosures…
…
continue reading

1
JCO at ASCO Annual Meeting: TTFields in Locally Advanced Pancreatic Adenocarcinoma
6:24
6:24
Play later
Play later
Lists
Like
Liked
6:24JCO Editorial Fellow Peter Li and JCO Associate Editor Eileen O'Reilly discuss the ASCO 25 Simultaneous Publication paper "Tumor-Treating Fields with Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal, Phase 3 PANOVA-3 Study." Transcript The guest on this podcast episode has no disclosures…
…
continue reading

1
JCO at ASCO Annual Meeting: Lenvatinib Plus Pembrolizumab and Chemotherapy in Gastric Cancer
6:52
6:52
Play later
Play later
Lists
Like
Liked
6:52JCO Editorial Fellow Dr. Peter Li and JCO Associate Editor Dr. Andrew Ko discuss the ASCO 25 Simultaneous Publication paper "Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III Randomized LEAP-015 Study." Transcript The guest on this podcast episode has no disclosu…
…
continue reading

1
JCO at ASCO Annual Meeting: Use of Low-Value Cancer Treatments in Medicare
8:17
8:17
Play later
Play later
Lists
Like
Liked
8:17JCO Editorial Fellow Dr. Lauren Shih and JCO Associate Editor Dr. Stephanie Wheeler discuss the ASCO 25 Simultaneous Publication paper "Use of Low-Value Cancer Treatments in Medicare Advantage Versus Traditional Medicare." Transcript The guest on this podcast episode has no disclosures to declare. Dr. Lauren Shih: Hello, and welcome to our 2025 ASC…
…
continue reading
In the first episode of a special daily series during the 2025 ASCO Annual Meeting, Dr. John Sweetenham discusses the results of 2 studies on the treatment of advanced colorectal cancer plus an additional study exploring the association of Medicaid expansion with cancer survival outcomes. Transcript Dr. John Sweetenham: Hello, and welcome to our sp…
…
continue reading

1
Pancreatic Cancer — Proceedings from the 2025 Annual ONS Congress
1:33:16
1:33:16
Play later
Play later
Lists
Like
Liked
1:33:16Drs Farshid Dayyani and Philip A Philip and oncology nursing professionals Caroline Kuhlman and Amanda K Wagner discuss datasets guiding treatment decision-making for patients with metastatic pancreatic cancer and strategies to mitigate and manage treatment-emergent adverse events. CME information and select publications here.…
…
continue reading

1
Pancreatic Cancer — Proceedings from the 2025 Annual ONS Congress
1:33:16
1:33:16
Play later
Play later
Lists
Like
Liked
1:33:16Drs Farshid Dayyani and Philip A Philip and oncology nursing professionals Caroline Kuhlman and Amanda K Wagner discuss datasets guiding treatment decision-making for patients with metastatic pancreatic cancer and strategies to mitigate and manage treatment-emergent adverse events. CME information and select publications here.…
…
continue reading

1
S13 Ep7: Evolving Molecular Profiling and Liquid Biopsy Practices Guide First-Line CRC Therapy Decisions: With Chandler Park, MD; and Midhun Malla, MD
9:09
9:09
Play later
Play later
Lists
Like
Liked
9:09Drs Park and Malla began by talking through the clinical utility of ctDNA in patients with stage II and III colon cancer. Dr Malla referenced the DYNAMIC (ACTRN12615000381583) and observational BESPOKE CRC (NCT04264702) trials, noting that ctDNA serves as a prognostic biomarker for recurrence and is increasingly used to guide post-surgical surveill…
…
continue reading

1
New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance
18:54
18:54
Play later
Play later
Lists
Like
Liked
18:54Interview with Thorir Einarsson Long, MD, PhD, and Ola Landgren, MD, PhD, authors of New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance. Hosted by Vivek Subbiah, MD. Related Content: New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance
…
continue reading
Our Landmarks of OncoPharm series returns to discuss the CLEOPATRA study, which established docetaxel, trastuzumab, pertuzumab (THP) as a standard first-line regimen for metastatic HER2-amplified breast cancer.By John Bossaer
…
continue reading

1
Multiple Myeloma — An Interview with Dr Rafael Fonseca on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting
50:50
50:50
Play later
Play later
Lists
Like
Liked
50:50Dr Rafael Fonseca from Mayo Clinic in Phoenix, Arizona, discusses datasets from the 2024 ASH meeting on the management of newly diagnosed and relapsed/refractory multiple myeloma. CME information and select publications here.By Dr. Neil Love
…
continue reading

1
JCO Article Insights: Double Hit Myeloma Correlates With Adverse Patient Outcome
15:50
15:50
Play later
Play later
Lists
Like
Liked
15:50In this JCO Article Insights episode, host Michael Hughes summarizes "Co-Occurrence of Cytogenetic Abnormalities and High-Risk Disease in Newly Diagnosed and Relapsed/Refractory Multiple Myeloma" by Kaiser et al, published February 18, 2025, followed by an interview with JCO Associate Editor Suzanne Lentzsch. Transcript Michael Hughes: Welcome to t…
…
continue reading

1
Cancer Matters with Dr Bill Nelson - Melanoma Research
14:52
14:52
Play later
Play later
Lists
Like
Liked
14:52Dr Bill Nelson talks with Dr Ashani Weeraratna about her work in melanoma research, the progress that has been made in treating patients with melanoma, and the importance of federal research funding in finding advancements in treatment for this disease.By Bill Nelson
…
continue reading
Smriti Patodia, Senior Editor of The Lancet Oncology, is joined by Professor Caroline Robert from Gustave Roussy Cancer Campus, France to discuss the EBIN trial on the use of a targeted-therapy induction regimen before treatment with immune checkpoint inhibitors in patients with metastatic melanoma with BRAFV600E or BRAFV600K mutations.…
…
continue reading

1
S13 Ep6: FDA Approval Insights: Perioperative Durvalumab Plus Chemo in MIBC: With Matthew Galsky, MD
7:48
7:48
Play later
Play later
Lists
Like
Liked
7:48In today’s episode, we spoke with Matthew Galsky, MD, about the FDA approval of neoadjuvant durvalumab (Imfinzi) plus gemcitabine and cisplatin followed by adjuvant durvalumab monotherapy after radical cystectomy for the treatment of adult patients with muscle-invasive bladder cancer (MIBC). Dr Galsky is a professor of medicine (hematology and medi…
…
continue reading

1
Multiple Myeloma — An Interview with Dr Rafael Fonseca on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting
50:50
50:50
Play later
Play later
Lists
Like
Liked
50:50Dr Rafael Fonseca from Mayo Clinic in Phoenix, Arizona, discusses datasets from the 2024 ASH meeting on the management of newly diagnosed and relapsed/refractory multiple myeloma. CME information and select publications here.By Dr. Neil Love
…
continue reading

1
5-Minute Journal Club Issue 8 with Dr Rinath M Jesselsohn: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer
13:48
13:48
Play later
Play later
Lists
Like
Liked
13:48Dr Rinath Jeselsohn from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent developments with oral SERDs in the management of ER-positive metastatic breast cancer. CME information and select publications here.By Dr. Neil Love
…
continue reading

1
5-Minute Journal Club Issue 8 with Dr Rinath M Jesselsohn: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer
13:48
13:48
Play later
Play later
Lists
Like
Liked
13:48Dr Rinath Jeselsohn from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent developments with oral SERDs in the management of ER-positive metastatic breast cancer. CME information and select publications here.By Dr. Neil Love
…
continue reading

1
S13 Ep5: Social Media Expands Access to Practical Public Health Education: With Chandler Park, MD; and Paul Hanona, MD
8:56
8:56
Play later
Play later
Lists
Like
Liked
8:56In this week’s episode of MedNews Week’s Oncology Unplugged, host Chandler Park, MD, a medical oncologist at Norton Cancer Institute in Louisville, Kentucky, was rejoined by Paul Hanona, MD, to give advice to up-and-coming oncology content creators. Dr Hanona is a content creator under the handle @doctordiscover. In the final part of this 3-part se…
…
continue reading

1
Gastroesophageal Cancer — Fourth Annual National General Medical Oncology Summit
52:32
52:32
Play later
Play later
Lists
Like
Liked
52:32Clinical investigators discuss available data guiding the management of gastroesophageal cancer. CME information and select publications here.By Dr. Neil Love
…
continue reading

1
Gastroesophageal Cancer — Fourth Annual National General Medical Oncology Summit
52:32
52:32
Play later
Play later
Lists
Like
Liked
52:32Clinical investigators discuss available data guiding the management of gastroesophageal cancer. CME information and select publications here.By Dr. Neil Love
…
continue reading

1
Chronic Lymphocytic Leukemia — An Interview with Dr Lindsey Roeker on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting
48:22
48:22
Play later
Play later
Lists
Like
Liked
48:22Dr Lindsey Roeker from Mayo Clinic in Rochester, Minnesota, discusses recent updates on available and novel treatment strategies for chronic lymphocytic leukemia. CME information and select publications here.By Dr. Neil Love
…
continue reading

1
Chronic Lymphocytic Leukemia — An Interview with Dr Lindsey Roeker on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting
48:22
48:22
Play later
Play later
Lists
Like
Liked
48:22Dr Lindsey Roeker from Mayo Clinic in Rochester, Minnesota, discusses recent updates on available and novel treatment strategies for chronic lymphocytic leukemia. CME information and select publications here.By Dr. Neil Love
…
continue reading

1
Relapsed/Refractory Follicular Lymphoma Part 3 — A Roundtable Discussion on the Selection and Sequencing of Other Novel Therapies
42:34
42:34
Play later
Play later
Lists
Like
Liked
42:34Dr Carla Casulo from Wilmot Cancer Institute in Rochester, New York, Dr Matthew Matasar from Rutgers Cancer Institute of New Jersey in New Brunswick and Dr Laurie H Sehn from BC Cancer Centre for Lymphoid Cancer in Vancouver discuss recent updates on available and novel treatment strategies for relapsed/refractory follicular lymphoma. CME informati…
…
continue reading

1
Relapsed/Refractory Follicular Lymphoma Part 3 — A Roundtable Discussion on the Selection and Sequencing of Other Novel Therapies
42:34
42:34
Play later
Play later
Lists
Like
Liked
42:34Dr Carla Casulo from Wilmot Cancer Institute in Rochester, New York, Dr Matthew Matasar from Rutgers Cancer Institute of New Jersey in New Brunswick and Dr Laurie H Sehn from BC Cancer Centre for Lymphoid Cancer in Vancouver discuss recent updates on available and novel treatment strategies for relapsed/refractory follicular lymphoma. CME informati…
…
continue reading

1
S13 Ep4: Eltrombopag Biosimilar Improves Accessibility for Immune Thrombocytopenia & Aplastic Anemia: With Kanwarpal S. Kahlon, MD
8:24
8:24
Play later
Play later
Lists
Like
Liked
8:24In today’s episode, supported by Camber Pharmaceuticals, we spoke with Kanwarpal S. Kahlon, MD, an associate clinical professor of medicine at the UCLA School of Medicine. In our exclusive interview, Dr Kahlon discussed the significance of the commercial availability of the generic, AB-rated formulations of eltrombopag (Promacta), a bioequivalent m…
…
continue reading

1
ASCO25 Preview: Key Research Accelerating Cancer Care
20:42
20:42
Play later
Play later
Lists
Like
Liked
20:42Dr. John Sweetenham and Dr. Erika Hamilton discuss top abstracts that will be presented at the 2025 ASCO Annual Meeting, including research on tech innovations that could shape the future of oncology. Transcript Dr. John Sweetenham: Hello, and welcome to the ASCO Daily News Podcast. I'm your host, Dr. John Sweetenham, and I'm delighted to be joined…
…
continue reading

1
Urothelial Bladder Cancer — Fourth Annual National General Medical Oncology Summit
49:01
49:01
Play later
Play later
Lists
Like
Liked
49:01Clinical investigators discuss available data guiding the management of urothelial bladder cancer. CME information and select publications here.By Dr. Neil Love
…
continue reading

1
Urothelial Bladder Cancer — Fourth Annual National General Medical Oncology Summit
49:01
49:01
Play later
Play later
Lists
Like
Liked
49:01Clinical investigators discuss available data guiding the management of urothelial bladder cancer. CME information and select publications here.By Dr. Neil Love
…
continue reading
If you've been struggling with how to talk to patients about ivermectin for cancer, then this podcast is for you.1. Cancer misinformation on social media (Loeb, et al): https://doi.org/10.3322/caac.218572. Clinician communication with patients about cancer misinformation (Bylund, et al): https://doi.org/10.1200/OP.22.00526…
…
continue reading
Discussing recent FDA approvals of penpulimab, avutometenib, defactinib, and telisotuzumab vedotin.By John Bossaer
…
continue reading

1
Cancer Matters with Dr Bill Nelson - Immunology Research
14:46
14:46
Play later
Play later
Lists
Like
Liked
14:46Dr Bill Nelson talks to Dr Drew Pardoll about the field of cancer immunology. They explain how cancer cells use 'checkpoints' to turn off immune response and how research efforts at Johns Hopkins to block these checkpoints and re-engage the immune system continue to benefit patients.By Bill Nelson
…
continue reading

1
Pancreatic Cancer — Fourth Annual National General Medical Oncology Summit
49:14
49:14
Play later
Play later
Lists
Like
Liked
49:14Clinical investigators discuss available data guiding the management of pancreatic cancer. CME information and select publications here.By Dr. Neil Love
…
continue reading

1
Pancreatic Cancer — Fourth Annual National General Medical Oncology Summit
49:14
49:14
Play later
Play later
Lists
Like
Liked
49:14Clinical investigators discuss available data guiding the management of pancreatic cancer. CME information and select publications here.By Dr. Neil Love
…
continue reading

1
Tanya Gupta, MD - Navigating the Clinical Integration of TROP2-Targeted ADCs in TNBC and HR+, HER2- Metastatic Breast Cancer: A Customized Learning Journey
52:59
52:59
Play later
Play later
Lists
Like
Liked
52:59This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/QJY865. C…
…
continue reading

1
Neal D. Shore, MD, FACS - Personalizing Prostate Cancer Care: Real-World Approaches for the Community Urology Practice
1:04:11
1:04:11
Play later
Play later
Lists
Like
Liked
1:04:11This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/CBJ865. CME/A…
…
continue reading

1
Non-Hodgkin Lymphoma — An Interview with Dr Jennifer Crombie on the Use of Bispecific Antibodies
49:54
49:54
Play later
Play later
Lists
Like
Liked
49:54Dr Jennifer Crombie from the Dana-Farber Cancer Institute in Boston, Massachusetts, reviews available and investigational CD20 x CD3 targeted bispecific antibodies for the treatment of follicular and diffuse large B-cell lymphomas. CME information and select publications here.By Dr. Neil Love
…
continue reading

1
Non-Hodgkin Lymphoma — An Interview with Dr Jennifer Crombie on the Use of Bispecific Antibodies
49:54
49:54
Play later
Play later
Lists
Like
Liked
49:54Dr Jennifer Crombie from the Dana-Farber Cancer Institute in Boston, Massachusetts, reviews available and investigational CD20 x CD3 targeted bispecific antibodies for the treatment of follicular and diffuse large B-cell lymphomas. CME information and select publications here.By Dr. Neil Love
…
continue reading

1
S13 Ep3: Updated Nilotinib Formulation Improves Treatment Adherence in Ph+ CML: With Michael J. Mauro, MD
12:59
12:59
Play later
Play later
Lists
Like
Liked
12:59In today’s episode, supported by Azurity Pharmaceuticals, we spoke with Michael J. Mauro, MD, about treatment adherence with nilotinib (Tasigna/Danziten) in patients with Philadelphia chromosome (Ph)–positive chronic myeloid leukemia (CML). Dr Mauro is an attending physician at Memorial Sloan Kettering Cancer Center in New York, New York. In our ex…
…
continue reading

1
5-Minute Journal Club Issue 7 with Dr Rinath M Jesselsohn: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer
17:35
17:35
Play later
Play later
Lists
Like
Liked
17:35Dr Rinath M Jeselsohn from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent developments with oral SERDs in the management of ER-positive metastatic breast cancer. CME information and select publications here.By Dr. Neil Love
…
continue reading

1
5-Minute Journal Club Issue 7 with Dr Rinath M Jesselsohn: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer
17:35
17:35
Play later
Play later
Lists
Like
Liked
17:35Dr Rinath M Jeselsohn from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent developments with oral SERDs in the management of ER-positive metastatic breast cancer. CME information and select publications here.By Dr. Neil Love
…
continue reading

1
S13 Ep2: Tailored Treatment Approaches for Older Patients With Advanced HR+/HER2– Breast Cancer
49:30
49:30
Play later
Play later
Lists
Like
Liked
49:30This featured podcast includes a discussion with 3 experts on managing patients with hormone receptor–positive/HER2-negative (HR+/HER2–) metastatic breast cancer (mBC) from a satellite symposium held in conjunction with the 42nd Annual Miami Breast Cancer Conference® in March 2025. In observational studies of treatment patterns in older women with …
…
continue reading
Dr. Chino talks with Dr. Erin Roesch and patient advocate Julia Maues about pregnancy associated cancer with a focus on breast cancer, the most common cancer diagnosed during pregnancy. This discussion is based off an JCO OP review article published in late 2024 called “Multidisciplinary Management of Pregnancy-Associated Breast Cancer.” Transcript…
…
continue reading

1
Immunotherapy and Nontargeted Approaches for NSCLC — Fourth Annual National General Medical Oncology Summit
50:15
50:15
Play later
Play later
Lists
Like
Liked
50:15Clinical investigators discuss available data guiding the management of non-small cell lung cancer with immunotherapy and other nontargeted approaches. CME information and select publications here.By Dr. Neil Love
…
continue reading

1
Immunotherapy and Nontargeted Approaches for NSCLC — Fourth Annual National General Medical Oncology Summit
50:15
50:15
Play later
Play later
Lists
Like
Liked
50:15Clinical investigators discuss available data guiding the management of non-small cell lung cancer with immunotherapy and other nontargeted approaches. CME information and select publications here.By Dr. Neil Love
…
continue reading

1
Colorectal Cancer — Fourth Annual National General Medical Oncology Summit
50:09
50:09
Play later
Play later
Lists
Like
Liked
50:09Clinical investigators discuss available data guiding the management of colorectal cancer. CME information and select publications here.By Dr. Neil Love
…
continue reading

1
Colorectal Cancer — Fourth Annual National General Medical Oncology Summit
50:09
50:09
Play later
Play later
Lists
Like
Liked
50:09Clinical investigators discuss available data guiding the management of colorectal cancer. CME information and select publications here.By Dr. Neil Love
…
continue reading

1
Angela Hirbe, MD, PhD - Bridging Gaps, Shaping Lifelong NF1 Care: Team Strategies and Management Choices With MEK Inhibitors Across the Pediatric-to-Adult Care Continuum
49:30
49:30
Play later
Play later
Lists
Like
Liked
49:30This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/EMS865. CME/A…
…
continue reading

1
Sia Daneshmand, MD - Putting Precision Into Practice for Bladder Cancer Treatment: Insights for Individualized Care Across the Disease Continuum
1:26:57
1:26:57
Play later
Play later
Lists
Like
Liked
1:26:57This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/BYQ865. C…
…
continue reading